ArticleEuropean radiology2022

Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements.

Nathalie A Hottat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.